circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis

Published:2023-11-24 Issue:22 Volume:15 Page:13329-13344
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Ju Linling¹,Zhou Qian²,Qi Qianyi³,She Yongjun¹,Cai Weihua¹,Cao Yali¹,Lu Rujian¹,Shao Jianguo¹,Chen Lin¹

Affiliation:

1. Medical School of Nantong University, Nantong University, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People`s Hospital, Nantong 226000, Jiangsu, China

2. Department of Gastroenterology, Changshu Second People’s Hospital, Changshu 215500, Jiangsu, China

3. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference29 articles.

1. Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.;Schwartz;Curr Oncol,2020

2. Hepatocellular carcinoma.;Bruix;Lancet,2018

3. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma.;Sharma;Clin Liver Dis,2020

4. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.;Zhang;Front Oncol,2020

5. Homeobox Genes and Hepatocellular Carcinoma.;Wang;Cancers (Basel),2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP